$0.749
-0.089 (-11.91%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CHRS Prediction & Forecast by Similar Chart Analysis
Alphio's CHRS stock price prediction model matches the current Coherus Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.75 (+0.03%). The 1-week path is $0.76 (+1.54%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Coherus Oncology Inc Stock?
Coherus BioSciences Inc (CHRS) appears to be a good buy at the current price of $0.7494, especially considering its RSI of 23.693, indicating it is oversold. The company has a strong gross margin of 70.35% in Q2 2026, which suggests efficient cost management and potential for profitability as revenues grow. However, the main risk is the forward P/E of 41.1523, indicating high expectations for future earnings that may not materialize, especially given the recent net income losses.
CHRS stock price ended at $0.75 on Thursday, after losing -11.91%
Coherus Oncology Inc (CHRS) last closed at $0.7489, losing -11.91%. These facts feed the 1-day and 1-week CHRS price prediction above.
Analyst Consensus
Coherus Oncology Inc (CHRS): 8 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Coherus Oncology Inc (CHRS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CHRS, ranked by similarity.
Seasonality analysis for CHRS
Historically the probability of a positive November return for CHRS is 9.30%. January offers the highest probability of a positive month at 44.26%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CHRS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $0.63 | $0.65 | $0.72 | -13.86% |
| Dec 2026 | $0.58 | $0.70 | $0.75 | -6.25% |
In 2026, Coherus Oncology Inc (CHRS) is projected to range from $0.58 to $0.75.
Coherus Oncology Inc 2026 monthly forecast
In Nov 2026, Coherus Oncology Inc is projected to average $0.65, with a low of $0.63 and high of $0.72.
In Dec 2026, Coherus Oncology Inc is projected to average $0.70, with a low of $0.58 and high of $0.75.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.